nodes	percent_of_prediction	percent_of_DWPC	metapath
Salicylate-sodium—PTGS2—bone cancer	0.764	1	CbGaD
Salicylate-sodium—PTGS2—Cisplatin—bone cancer	0.0817	1	CbGbCtD
Salicylate-sodium—Acetylsalicylic acid—TP53—bone cancer	0.00305	0.464	CrCbGaD
Salicylate-sodium—Magnesium salicylate—PTGS2—bone cancer	0.00094	0.143	CrCbGaD
Salicylate-sodium—Salsalate—PTGS2—bone cancer	0.0008	0.122	CrCbGaD
Salicylate-sodium—Irritability—Cisplatin—bone cancer	0.000736	0.00502	CcSEcCtD
Salicylate-sodium—Burning sensation—Doxorubicin—bone cancer	0.000727	0.00495	CcSEcCtD
Salicylate-sodium—Blood creatinine increased—Cisplatin—bone cancer	0.000723	0.00492	CcSEcCtD
Salicylate-sodium—Dehydration—Cisplatin—bone cancer	0.000718	0.00489	CcSEcCtD
Salicylate-sodium—Hypokalaemia—Cisplatin—bone cancer	0.000702	0.00478	CcSEcCtD
Salicylate-sodium—Necrosis—Epirubicin—bone cancer	0.000695	0.00474	CcSEcCtD
Salicylate-sodium—Feeling hot—Epirubicin—bone cancer	0.000695	0.00474	CcSEcCtD
Salicylate-sodium—Mesalazine—PTGS2—bone cancer	0.000694	0.105	CrCbGaD
Salicylate-sodium—Abscess—Epirubicin—bone cancer	0.00069	0.0047	CcSEcCtD
Salicylate-sodium—Stinging—Epirubicin—bone cancer	0.000674	0.00459	CcSEcCtD
Salicylate-sodium—Extravasation—Methotrexate—bone cancer	0.000669	0.00455	CcSEcCtD
Salicylate-sodium—Sweating increased—Cisplatin—bone cancer	0.00065	0.00442	CcSEcCtD
Salicylate-sodium—Necrosis—Doxorubicin—bone cancer	0.000644	0.00438	CcSEcCtD
Salicylate-sodium—Feeling hot—Doxorubicin—bone cancer	0.000644	0.00438	CcSEcCtD
Salicylate-sodium—Abdominal discomfort—Cisplatin—bone cancer	0.000639	0.00435	CcSEcCtD
Salicylate-sodium—Abscess—Doxorubicin—bone cancer	0.000638	0.00435	CcSEcCtD
Salicylate-sodium—Oliguria—Methotrexate—bone cancer	0.000633	0.00431	CcSEcCtD
Salicylate-sodium—Extravasation—Epirubicin—bone cancer	0.000626	0.00426	CcSEcCtD
Salicylate-sodium—Stinging—Doxorubicin—bone cancer	0.000623	0.00425	CcSEcCtD
Salicylate-sodium—Ulcer—Methotrexate—bone cancer	0.000617	0.0042	CcSEcCtD
Salicylate-sodium—Cellulitis—Epirubicin—bone cancer	0.0006	0.00409	CcSEcCtD
Salicylate-sodium—Acetylsalicylic acid—PTGS2—bone cancer	0.000597	0.0908	CrCbGaD
Salicylate-sodium—Hypocalcaemia—Epirubicin—bone cancer	0.000596	0.00406	CcSEcCtD
Salicylate-sodium—Oliguria—Epirubicin—bone cancer	0.000592	0.00403	CcSEcCtD
Salicylate-sodium—Acute coronary syndrome—Cisplatin—bone cancer	0.000586	0.00399	CcSEcCtD
Salicylate-sodium—Renal failure—Cisplatin—bone cancer	0.000585	0.00398	CcSEcCtD
Salicylate-sodium—Myocardial infarction—Cisplatin—bone cancer	0.000583	0.00397	CcSEcCtD
Salicylate-sodium—Extravasation—Doxorubicin—bone cancer	0.000579	0.00394	CcSEcCtD
Salicylate-sodium—Ulcer—Epirubicin—bone cancer	0.000577	0.00393	CcSEcCtD
Salicylate-sodium—Creatinine increased—Epirubicin—bone cancer	0.000573	0.00391	CcSEcCtD
Salicylate-sodium—Skin exfoliation—Methotrexate—bone cancer	0.000557	0.00379	CcSEcCtD
Salicylate-sodium—Cellulitis—Doxorubicin—bone cancer	0.000555	0.00378	CcSEcCtD
Salicylate-sodium—Hypocalcaemia—Doxorubicin—bone cancer	0.000552	0.00376	CcSEcCtD
Salicylate-sodium—Oliguria—Doxorubicin—bone cancer	0.000548	0.00373	CcSEcCtD
Salicylate-sodium—Ulcer—Doxorubicin—bone cancer	0.000534	0.00364	CcSEcCtD
Salicylate-sodium—Creatinine increased—Doxorubicin—bone cancer	0.000531	0.00361	CcSEcCtD
Salicylate-sodium—Ecchymosis—Methotrexate—bone cancer	0.000527	0.00359	CcSEcCtD
Salicylate-sodium—Skin exfoliation—Epirubicin—bone cancer	0.000521	0.00355	CcSEcCtD
Salicylate-sodium—Fluid retention—Epirubicin—bone cancer	0.000518	0.00353	CcSEcCtD
Salicylate-sodium—Blood urea increased—Epirubicin—bone cancer	0.000515	0.00351	CcSEcCtD
Salicylate-sodium—Sepsis—Methotrexate—bone cancer	0.000506	0.00345	CcSEcCtD
Salicylate-sodium—Oesophagitis—Epirubicin—bone cancer	0.000499	0.0034	CcSEcCtD
Salicylate-sodium—Tinnitus—Cisplatin—bone cancer	0.000498	0.00339	CcSEcCtD
Salicylate-sodium—Ecchymosis—Epirubicin—bone cancer	0.000494	0.00336	CcSEcCtD
Salicylate-sodium—Salicylic acid—PTGS2—bone cancer	0.000492	0.0748	CrCbGaD
Salicylate-sodium—Skin exfoliation—Doxorubicin—bone cancer	0.000482	0.00328	CcSEcCtD
Salicylate-sodium—Fluid retention—Doxorubicin—bone cancer	0.00048	0.00327	CcSEcCtD
Salicylate-sodium—Arrhythmia—Cisplatin—bone cancer	0.000477	0.00325	CcSEcCtD
Salicylate-sodium—Blood urea increased—Doxorubicin—bone cancer	0.000477	0.00325	CcSEcCtD
Salicylate-sodium—Sepsis—Epirubicin—bone cancer	0.000474	0.00323	CcSEcCtD
Salicylate-sodium—Erythema—Cisplatin—bone cancer	0.000465	0.00316	CcSEcCtD
Salicylate-sodium—Oesophagitis—Doxorubicin—bone cancer	0.000462	0.00314	CcSEcCtD
Salicylate-sodium—Phlebitis—Epirubicin—bone cancer	0.00046	0.00313	CcSEcCtD
Salicylate-sodium—Renal failure acute—Methotrexate—bone cancer	0.000459	0.00312	CcSEcCtD
Salicylate-sodium—Flatulence—Cisplatin—bone cancer	0.000458	0.00312	CcSEcCtD
Salicylate-sodium—Ecchymosis—Doxorubicin—bone cancer	0.000457	0.00311	CcSEcCtD
Salicylate-sodium—Sepsis—Doxorubicin—bone cancer	0.000438	0.00298	CcSEcCtD
Salicylate-sodium—Vision blurred—Cisplatin—bone cancer	0.000438	0.00298	CcSEcCtD
Salicylate-sodium—Cardiac failure congestive—Epirubicin—bone cancer	0.000437	0.00298	CcSEcCtD
Salicylate-sodium—Cerebrovascular accident—Methotrexate—bone cancer	0.000432	0.00294	CcSEcCtD
Salicylate-sodium—Lethargy—Methotrexate—bone cancer	0.000432	0.00294	CcSEcCtD
Salicylate-sodium—Renal failure acute—Epirubicin—bone cancer	0.000429	0.00292	CcSEcCtD
Salicylate-sodium—Phlebitis—Doxorubicin—bone cancer	0.000426	0.0029	CcSEcCtD
Salicylate-sodium—Renal impairment—Epirubicin—bone cancer	0.000416	0.00284	CcSEcCtD
Salicylate-sodium—Lethargy—Epirubicin—bone cancer	0.000404	0.00275	CcSEcCtD
Salicylate-sodium—Cerebrovascular accident—Epirubicin—bone cancer	0.000404	0.00275	CcSEcCtD
Salicylate-sodium—Cardiac failure congestive—Doxorubicin—bone cancer	0.000404	0.00275	CcSEcCtD
Salicylate-sodium—Irritability—Methotrexate—bone cancer	0.000404	0.00275	CcSEcCtD
Salicylate-sodium—Convulsion—Cisplatin—bone cancer	0.000403	0.00274	CcSEcCtD
Salicylate-sodium—Renal failure acute—Doxorubicin—bone cancer	0.000397	0.0027	CcSEcCtD
Salicylate-sodium—Anxiety—Cisplatin—bone cancer	0.000394	0.00268	CcSEcCtD
Salicylate-sodium—Renal impairment—Doxorubicin—bone cancer	0.000385	0.00262	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Cisplatin—bone cancer	0.000379	0.00258	CcSEcCtD
Salicylate-sodium—Oedema—Cisplatin—bone cancer	0.000379	0.00258	CcSEcCtD
Salicylate-sodium—Infection—Cisplatin—bone cancer	0.000377	0.00257	CcSEcCtD
Salicylate-sodium—Lethargy—Doxorubicin—bone cancer	0.000374	0.00255	CcSEcCtD
Salicylate-sodium—Cerebrovascular accident—Doxorubicin—bone cancer	0.000374	0.00255	CcSEcCtD
Salicylate-sodium—Blood creatinine increased—Epirubicin—bone cancer	0.000371	0.00253	CcSEcCtD
Salicylate-sodium—Tachycardia—Cisplatin—bone cancer	0.00037	0.00252	CcSEcCtD
Salicylate-sodium—Dehydration—Epirubicin—bone cancer	0.000368	0.00251	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Cisplatin—bone cancer	0.000367	0.0025	CcSEcCtD
Salicylate-sodium—Asthma—Methotrexate—bone cancer	0.000366	0.00249	CcSEcCtD
Salicylate-sodium—Abdominal pain upper—Epirubicin—bone cancer	0.000362	0.00246	CcSEcCtD
Salicylate-sodium—Anorexia—Cisplatin—bone cancer	0.000361	0.00246	CcSEcCtD
Salicylate-sodium—Hypokalaemia—Epirubicin—bone cancer	0.000361	0.00246	CcSEcCtD
Salicylate-sodium—Hypotension—Cisplatin—bone cancer	0.000354	0.00241	CcSEcCtD
Salicylate-sodium—Abdominal discomfort—Methotrexate—bone cancer	0.000351	0.00239	CcSEcCtD
Salicylate-sodium—Abdominal distension—Epirubicin—bone cancer	0.000345	0.00235	CcSEcCtD
Salicylate-sodium—Blood creatinine increased—Doxorubicin—bone cancer	0.000343	0.00234	CcSEcCtD
Salicylate-sodium—Asthma—Epirubicin—bone cancer	0.000342	0.00233	CcSEcCtD
Salicylate-sodium—Dysphagia—Epirubicin—bone cancer	0.000342	0.00233	CcSEcCtD
Salicylate-sodium—Dehydration—Doxorubicin—bone cancer	0.000341	0.00232	CcSEcCtD
Salicylate-sodium—Paraesthesia—Cisplatin—bone cancer	0.000341	0.00232	CcSEcCtD
Salicylate-sodium—Dyspnoea—Cisplatin—bone cancer	0.000338	0.0023	CcSEcCtD
Salicylate-sodium—Abdominal pain upper—Doxorubicin—bone cancer	0.000335	0.00228	CcSEcCtD
Salicylate-sodium—Hypokalaemia—Doxorubicin—bone cancer	0.000334	0.00227	CcSEcCtD
Salicylate-sodium—Decreased appetite—Cisplatin—bone cancer	0.00033	0.00225	CcSEcCtD
Salicylate-sodium—Bronchitis—Epirubicin—bone cancer	0.000329	0.00224	CcSEcCtD
Salicylate-sodium—Drowsiness—Methotrexate—bone cancer	0.000326	0.00222	CcSEcCtD
Salicylate-sodium—Pain—Cisplatin—bone cancer	0.000324	0.00221	CcSEcCtD
Salicylate-sodium—Renal failure—Methotrexate—bone cancer	0.000321	0.00218	CcSEcCtD
Salicylate-sodium—Abdominal distension—Doxorubicin—bone cancer	0.000319	0.00217	CcSEcCtD
Salicylate-sodium—Asthma—Doxorubicin—bone cancer	0.000317	0.00216	CcSEcCtD
Salicylate-sodium—Dysphagia—Doxorubicin—bone cancer	0.000317	0.00216	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Cisplatin—bone cancer	0.000313	0.00213	CcSEcCtD
Salicylate-sodium—Weight increased—Epirubicin—bone cancer	0.000312	0.00212	CcSEcCtD
Salicylate-sodium—Epistaxis—Methotrexate—bone cancer	0.000308	0.0021	CcSEcCtD
Salicylate-sodium—Drowsiness—Epirubicin—bone cancer	0.000305	0.00208	CcSEcCtD
Salicylate-sodium—Bronchitis—Doxorubicin—bone cancer	0.000305	0.00208	CcSEcCtD
Salicylate-sodium—Renal failure—Epirubicin—bone cancer	0.0003	0.00204	CcSEcCtD
Salicylate-sodium—Body temperature increased—Cisplatin—bone cancer	0.0003	0.00204	CcSEcCtD
Salicylate-sodium—Hepatitis—Methotrexate—bone cancer	0.000293	0.00199	CcSEcCtD
Salicylate-sodium—Weight increased—Doxorubicin—bone cancer	0.000288	0.00196	CcSEcCtD
Salicylate-sodium—Epistaxis—Epirubicin—bone cancer	0.000288	0.00196	CcSEcCtD
Salicylate-sodium—Drowsiness—Doxorubicin—bone cancer	0.000283	0.00192	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Cisplatin—bone cancer	0.000279	0.0019	CcSEcCtD
Salicylate-sodium—Renal failure—Doxorubicin—bone cancer	0.000278	0.00189	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Methotrexate—bone cancer	0.000277	0.00189	CcSEcCtD
Salicylate-sodium—Hepatitis—Epirubicin—bone cancer	0.000274	0.00187	CcSEcCtD
Salicylate-sodium—Tinnitus—Methotrexate—bone cancer	0.000273	0.00186	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Epirubicin—bone cancer	0.000273	0.00186	CcSEcCtD
Salicylate-sodium—Asthenia—Cisplatin—bone cancer	0.000272	0.00185	CcSEcCtD
Salicylate-sodium—Epistaxis—Doxorubicin—bone cancer	0.000266	0.00181	CcSEcCtD
Salicylate-sodium—Diarrhoea—Cisplatin—bone cancer	0.000259	0.00177	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Epirubicin—bone cancer	0.000259	0.00177	CcSEcCtD
Salicylate-sodium—Tinnitus—Epirubicin—bone cancer	0.000256	0.00174	CcSEcCtD
Salicylate-sodium—Erythema—Methotrexate—bone cancer	0.000255	0.00174	CcSEcCtD
Salicylate-sodium—Hepatitis—Doxorubicin—bone cancer	0.000254	0.00173	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Doxorubicin—bone cancer	0.000252	0.00172	CcSEcCtD
Salicylate-sodium—Dysgeusia—Methotrexate—bone cancer	0.00025	0.0017	CcSEcCtD
Salicylate-sodium—Arrhythmia—Epirubicin—bone cancer	0.000245	0.00167	CcSEcCtD
Salicylate-sodium—Vomiting—Cisplatin—bone cancer	0.000241	0.00164	CcSEcCtD
Salicylate-sodium—Vision blurred—Methotrexate—bone cancer	0.00024	0.00164	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Doxorubicin—bone cancer	0.00024	0.00163	CcSEcCtD
Salicylate-sodium—Rash—Cisplatin—bone cancer	0.000239	0.00163	CcSEcCtD
Salicylate-sodium—Dermatitis—Cisplatin—bone cancer	0.000239	0.00163	CcSEcCtD
Salicylate-sodium—Erythema—Epirubicin—bone cancer	0.000239	0.00163	CcSEcCtD
Salicylate-sodium—Tinnitus—Doxorubicin—bone cancer	0.000236	0.00161	CcSEcCtD
Salicylate-sodium—Flatulence—Epirubicin—bone cancer	0.000235	0.0016	CcSEcCtD
Salicylate-sodium—Dysgeusia—Epirubicin—bone cancer	0.000234	0.00159	CcSEcCtD
Salicylate-sodium—Arrhythmia—Doxorubicin—bone cancer	0.000227	0.00154	CcSEcCtD
Salicylate-sodium—Nausea—Cisplatin—bone cancer	0.000225	0.00153	CcSEcCtD
Salicylate-sodium—Vision blurred—Epirubicin—bone cancer	0.000225	0.00153	CcSEcCtD
Salicylate-sodium—Convulsion—Methotrexate—bone cancer	0.000221	0.0015	CcSEcCtD
Salicylate-sodium—Erythema—Doxorubicin—bone cancer	0.000221	0.0015	CcSEcCtD
Salicylate-sodium—Flatulence—Doxorubicin—bone cancer	0.000218	0.00148	CcSEcCtD
Salicylate-sodium—Chest pain—Methotrexate—bone cancer	0.000217	0.00148	CcSEcCtD
Salicylate-sodium—Dysgeusia—Doxorubicin—bone cancer	0.000216	0.00147	CcSEcCtD
Salicylate-sodium—Syncope—Epirubicin—bone cancer	0.000214	0.00146	CcSEcCtD
Salicylate-sodium—Palpitations—Epirubicin—bone cancer	0.000211	0.00144	CcSEcCtD
Salicylate-sodium—Confusional state—Methotrexate—bone cancer	0.00021	0.00143	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Epirubicin—bone cancer	0.00021	0.00143	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Methotrexate—bone cancer	0.000208	0.00142	CcSEcCtD
Salicylate-sodium—Vision blurred—Doxorubicin—bone cancer	0.000208	0.00142	CcSEcCtD
Salicylate-sodium—Convulsion—Epirubicin—bone cancer	0.000207	0.00141	CcSEcCtD
Salicylate-sodium—Infection—Methotrexate—bone cancer	0.000207	0.00141	CcSEcCtD
Salicylate-sodium—Chest pain—Epirubicin—bone cancer	0.000203	0.00138	CcSEcCtD
Salicylate-sodium—Anxiety—Epirubicin—bone cancer	0.000202	0.00138	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Methotrexate—bone cancer	0.000201	0.00137	CcSEcCtD
Salicylate-sodium—Anorexia—Methotrexate—bone cancer	0.000198	0.00135	CcSEcCtD
Salicylate-sodium—Syncope—Doxorubicin—bone cancer	0.000198	0.00135	CcSEcCtD
Salicylate-sodium—Confusional state—Epirubicin—bone cancer	0.000196	0.00134	CcSEcCtD
Salicylate-sodium—Palpitations—Doxorubicin—bone cancer	0.000195	0.00133	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Epirubicin—bone cancer	0.000195	0.00133	CcSEcCtD
Salicylate-sodium—Oedema—Epirubicin—bone cancer	0.000195	0.00133	CcSEcCtD
Salicylate-sodium—Hypotension—Methotrexate—bone cancer	0.000194	0.00132	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Doxorubicin—bone cancer	0.000194	0.00132	CcSEcCtD
Salicylate-sodium—Infection—Epirubicin—bone cancer	0.000193	0.00132	CcSEcCtD
Salicylate-sodium—Shock—Epirubicin—bone cancer	0.000192	0.0013	CcSEcCtD
Salicylate-sodium—Convulsion—Doxorubicin—bone cancer	0.000191	0.0013	CcSEcCtD
Salicylate-sodium—Tachycardia—Epirubicin—bone cancer	0.00019	0.00129	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Epirubicin—bone cancer	0.000188	0.00128	CcSEcCtD
Salicylate-sodium—Chest pain—Doxorubicin—bone cancer	0.000188	0.00128	CcSEcCtD
Salicylate-sodium—Anxiety—Doxorubicin—bone cancer	0.000187	0.00128	CcSEcCtD
Salicylate-sodium—Paraesthesia—Methotrexate—bone cancer	0.000187	0.00127	CcSEcCtD
Salicylate-sodium—Anorexia—Epirubicin—bone cancer	0.000186	0.00126	CcSEcCtD
Salicylate-sodium—Dyspnoea—Methotrexate—bone cancer	0.000186	0.00126	CcSEcCtD
Salicylate-sodium—Somnolence—Methotrexate—bone cancer	0.000185	0.00126	CcSEcCtD
Salicylate-sodium—Dyspepsia—Methotrexate—bone cancer	0.000183	0.00125	CcSEcCtD
Salicylate-sodium—Hypotension—Epirubicin—bone cancer	0.000182	0.00124	CcSEcCtD
Salicylate-sodium—Confusional state—Doxorubicin—bone cancer	0.000182	0.00124	CcSEcCtD
Salicylate-sodium—Decreased appetite—Methotrexate—bone cancer	0.000181	0.00123	CcSEcCtD
Salicylate-sodium—Oedema—Doxorubicin—bone cancer	0.00018	0.00123	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Doxorubicin—bone cancer	0.00018	0.00123	CcSEcCtD
Salicylate-sodium—Fatigue—Methotrexate—bone cancer	0.000179	0.00122	CcSEcCtD
Salicylate-sodium—Infection—Doxorubicin—bone cancer	0.000179	0.00122	CcSEcCtD
Salicylate-sodium—Pain—Methotrexate—bone cancer	0.000178	0.00121	CcSEcCtD
Salicylate-sodium—Shock—Doxorubicin—bone cancer	0.000177	0.00121	CcSEcCtD
Salicylate-sodium—Tachycardia—Doxorubicin—bone cancer	0.000176	0.0012	CcSEcCtD
Salicylate-sodium—Paraesthesia—Epirubicin—bone cancer	0.000175	0.00119	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Doxorubicin—bone cancer	0.000174	0.00119	CcSEcCtD
Salicylate-sodium—Dyspnoea—Epirubicin—bone cancer	0.000174	0.00118	CcSEcCtD
Salicylate-sodium—Somnolence—Epirubicin—bone cancer	0.000173	0.00118	CcSEcCtD
Salicylate-sodium—Anorexia—Doxorubicin—bone cancer	0.000172	0.00117	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Methotrexate—bone cancer	0.000171	0.00117	CcSEcCtD
Salicylate-sodium—Dyspepsia—Epirubicin—bone cancer	0.000171	0.00117	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Methotrexate—bone cancer	0.00017	0.00116	CcSEcCtD
Salicylate-sodium—Decreased appetite—Epirubicin—bone cancer	0.000169	0.00115	CcSEcCtD
Salicylate-sodium—Hypotension—Doxorubicin—bone cancer	0.000168	0.00115	CcSEcCtD
Salicylate-sodium—Fatigue—Epirubicin—bone cancer	0.000168	0.00114	CcSEcCtD
Salicylate-sodium—Pain—Epirubicin—bone cancer	0.000167	0.00113	CcSEcCtD
Salicylate-sodium—Constipation—Epirubicin—bone cancer	0.000167	0.00113	CcSEcCtD
Salicylate-sodium—Urticaria—Methotrexate—bone cancer	0.000165	0.00113	CcSEcCtD
Salicylate-sodium—Abdominal pain—Methotrexate—bone cancer	0.000165	0.00112	CcSEcCtD
Salicylate-sodium—Body temperature increased—Methotrexate—bone cancer	0.000165	0.00112	CcSEcCtD
Salicylate-sodium—Paraesthesia—Doxorubicin—bone cancer	0.000162	0.0011	CcSEcCtD
Salicylate-sodium—Dyspnoea—Doxorubicin—bone cancer	0.000161	0.00109	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Epirubicin—bone cancer	0.00016	0.00109	CcSEcCtD
Salicylate-sodium—Somnolence—Doxorubicin—bone cancer	0.00016	0.00109	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Epirubicin—bone cancer	0.000159	0.00108	CcSEcCtD
Salicylate-sodium—Dyspepsia—Doxorubicin—bone cancer	0.000159	0.00108	CcSEcCtD
Salicylate-sodium—Decreased appetite—Doxorubicin—bone cancer	0.000157	0.00107	CcSEcCtD
Salicylate-sodium—Fatigue—Doxorubicin—bone cancer	0.000155	0.00106	CcSEcCtD
Salicylate-sodium—Urticaria—Epirubicin—bone cancer	0.000155	0.00105	CcSEcCtD
Salicylate-sodium—Constipation—Doxorubicin—bone cancer	0.000154	0.00105	CcSEcCtD
Salicylate-sodium—Pain—Doxorubicin—bone cancer	0.000154	0.00105	CcSEcCtD
Salicylate-sodium—Abdominal pain—Epirubicin—bone cancer	0.000154	0.00105	CcSEcCtD
Salicylate-sodium—Body temperature increased—Epirubicin—bone cancer	0.000154	0.00105	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Methotrexate—bone cancer	0.000153	0.00104	CcSEcCtD
Salicylate-sodium—Asthenia—Methotrexate—bone cancer	0.000149	0.00102	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Doxorubicin—bone cancer	0.000148	0.00101	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Doxorubicin—bone cancer	0.000147	0.001	CcSEcCtD
Salicylate-sodium—Pruritus—Methotrexate—bone cancer	0.000147	0.001	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Epirubicin—bone cancer	0.000143	0.000977	CcSEcCtD
Salicylate-sodium—Urticaria—Doxorubicin—bone cancer	0.000143	0.000975	CcSEcCtD
Salicylate-sodium—Body temperature increased—Doxorubicin—bone cancer	0.000142	0.00097	CcSEcCtD
Salicylate-sodium—Abdominal pain—Doxorubicin—bone cancer	0.000142	0.00097	CcSEcCtD
Salicylate-sodium—Diarrhoea—Methotrexate—bone cancer	0.000142	0.00097	CcSEcCtD
Salicylate-sodium—Asthenia—Epirubicin—bone cancer	0.00014	0.000952	CcSEcCtD
Salicylate-sodium—Pruritus—Epirubicin—bone cancer	0.000138	0.000938	CcSEcCtD
Salicylate-sodium—Dizziness—Methotrexate—bone cancer	0.000138	0.000937	CcSEcCtD
Salicylate-sodium—Diarrhoea—Epirubicin—bone cancer	0.000133	0.000907	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Doxorubicin—bone cancer	0.000133	0.000904	CcSEcCtD
Salicylate-sodium—Vomiting—Methotrexate—bone cancer	0.000132	0.000901	CcSEcCtD
Salicylate-sodium—Rash—Methotrexate—bone cancer	0.000131	0.000894	CcSEcCtD
Salicylate-sodium—Dermatitis—Methotrexate—bone cancer	0.000131	0.000893	CcSEcCtD
Salicylate-sodium—Headache—Methotrexate—bone cancer	0.00013	0.000888	CcSEcCtD
Salicylate-sodium—Asthenia—Doxorubicin—bone cancer	0.000129	0.000881	CcSEcCtD
Salicylate-sodium—Dizziness—Epirubicin—bone cancer	0.000129	0.000877	CcSEcCtD
Salicylate-sodium—Pruritus—Doxorubicin—bone cancer	0.000127	0.000868	CcSEcCtD
Salicylate-sodium—Vomiting—Epirubicin—bone cancer	0.000124	0.000843	CcSEcCtD
Salicylate-sodium—Nausea—Methotrexate—bone cancer	0.000124	0.000842	CcSEcCtD
Salicylate-sodium—Diarrhoea—Doxorubicin—bone cancer	0.000123	0.00084	CcSEcCtD
Salicylate-sodium—Rash—Epirubicin—bone cancer	0.000123	0.000836	CcSEcCtD
Salicylate-sodium—Dermatitis—Epirubicin—bone cancer	0.000123	0.000836	CcSEcCtD
Salicylate-sodium—Headache—Epirubicin—bone cancer	0.000122	0.000831	CcSEcCtD
Salicylate-sodium—Dizziness—Doxorubicin—bone cancer	0.000119	0.000812	CcSEcCtD
Salicylate-sodium—Nausea—Epirubicin—bone cancer	0.000116	0.000788	CcSEcCtD
Salicylate-sodium—Vomiting—Doxorubicin—bone cancer	0.000115	0.00078	CcSEcCtD
Salicylate-sodium—Rash—Doxorubicin—bone cancer	0.000114	0.000774	CcSEcCtD
Salicylate-sodium—Dermatitis—Doxorubicin—bone cancer	0.000114	0.000773	CcSEcCtD
Salicylate-sodium—Headache—Doxorubicin—bone cancer	0.000113	0.000769	CcSEcCtD
Salicylate-sodium—Nausea—Doxorubicin—bone cancer	0.000107	0.000729	CcSEcCtD
Salicylate-sodium—PTGS2—periosteum—bone cancer	8.97e-05	0.209	CbGeAlD
Salicylate-sodium—PTGS2—leg—bone cancer	7.15e-05	0.167	CbGeAlD
Salicylate-sodium—PTGS2—hindlimb—bone cancer	6.39e-05	0.149	CbGeAlD
Salicylate-sodium—PTGS2—cartilage tissue—bone cancer	6.29e-05	0.147	CbGeAlD
Salicylate-sodium—PTGS2—appendage—bone cancer	5.48e-05	0.128	CbGeAlD
Salicylate-sodium—PTGS1—connective tissue—bone cancer	1.64e-05	0.0382	CbGeAlD
Salicylate-sodium—PTGS2—connective tissue—bone cancer	1.56e-05	0.0365	CbGeAlD
Salicylate-sodium—PTGS1—tendon—bone cancer	1.12e-05	0.0263	CbGeAlD
Salicylate-sodium—PTGS1—spinal cord—bone cancer	1.08e-05	0.0253	CbGeAlD
Salicylate-sodium—PTGS2—tendon—bone cancer	1.07e-05	0.0251	CbGeAlD
Salicylate-sodium—PTGS2—bone marrow—bone cancer	1.04e-05	0.0243	CbGeAlD
Salicylate-sodium—PTGS2—spinal cord—bone cancer	1.04e-05	0.0242	CbGeAlD
